Giuseppe Giaccone, MD, PhD, highlights the difficulties with funding for research focused on rare cancers.
Giuseppe Giaccone, MD, PhD
Advertisement
Articles by Giuseppe Giaccone, MD, PhD
Giuseppe Giaccone, MD, PhD, discusses recent data with investigational therapies for patients with thymic cancer.
Giuseppe Giaconne, MD, PhD, discusses why thymic cancers can be difficult to classify histologically, so the actual incidence is unclear.
Giuseppe Giaconne, MD, PhD, and Yongfeng He, PhD, discuss how cancers of the thymus, a small organ located in the mediastinum above the heart, are uncommon and understudied.

Giuseppe Giaccone, MD, PhD, discusses current treatment options in non–small cell lung cancer.
Advertisement
Latest Updated Articles
Dr. Giaccone on Treatment Options in NSCLCOctober 1st 2020
- Dr. Giaccone on Investigational Agents in Thymic Cancers
October 21st 2022
Advertisement
Advertisement
Trending on OncLive
1
FDA Clears TumorSight Risk, an MRI-Derived AI Recurrence Tool for HR+, HER2– Breast Cancer
2
Dr Cercek on the FDA Approval of Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
3
Vilamakitug Meets OS Threshold in Phase 1/2 Refractory mCRC Trial
4
Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape
5
